Sankey dot pathway enrichment displayed the KEGG pathway enrichment, which included Proteoglycans in cancer, EGFR tyrosine kinase inhibitor resistance, Pathways in cancer, Hepatitis B, PD-L1 expression and PD-1 checkpoint pathway in cancer, Endocrine resistance, and MicroRNAs in cancer. The gene discussed is CD274; the disease is cancer.